Wells Fargo & Company Issues Positive Forecast for Omega Healthcare Investors (NYSE:OHI) Stock Price

by · The Markets Daily

Omega Healthcare Investors (NYSE:OHI – Get Free Report) had its target price lifted by investment analysts at Wells Fargo & Company from $47.00 to $49.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 6.17% from the stock’s previous close.

Other equities analysts have also recently issued reports about the company. Bank of America reissued an “underperform” rating and set a $46.00 price target (down from $52.00) on shares of Omega Healthcare Investors in a report on Tuesday, April 14th. UBS Group increased their price target on Omega Healthcare Investors from $52.00 to $54.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Cantor Fitzgerald increased their price target on Omega Healthcare Investors from $50.00 to $52.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Citigroup increased their price target on Omega Healthcare Investors from $50.00 to $52.00 and gave the company a “buy” rating in a report on Friday, May 1st. Finally, Royal Bank Of Canada increased their price target on Omega Healthcare Investors from $47.00 to $48.00 and gave the company a “sector perform” rating in a report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $49.17.

View Our Latest Stock Report on Omega Healthcare Investors

Omega Healthcare Investors Stock Down 1.3%

OHI stock traded down $0.61 during midday trading on Monday, hitting $46.15. The company’s stock had a trading volume of 345,982 shares, compared to its average volume of 2,078,392. The company has a market cap of $13.74 billion, a PE ratio of 22.29, a P/E/G ratio of 2.01 and a beta of 0.58. Omega Healthcare Investors has a 12 month low of $35.70 and a 12 month high of $49.33. The company has a current ratio of 5.32, a quick ratio of 5.32 and a debt-to-equity ratio of 0.81. The firm’s 50-day moving average is $46.35 and its 200-day moving average is $45.70.

Omega Healthcare Investors (NYSE:OHI – Get Free Report) last released its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.02). The business had revenue of $322.96 million during the quarter, compared to the consensus estimate of $264.07 million. Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The business’s revenue was up 16.7% compared to the same quarter last year. During the same period last year, the company posted $0.75 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. On average, equities research analysts forecast that Omega Healthcare Investors will post 3.07 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of institutional investors have recently bought and sold shares of the business. Resources Management Corp CT ADV boosted its holdings in shares of Omega Healthcare Investors by 300.0% during the 4th quarter. Resources Management Corp CT ADV now owns 600 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 450 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Omega Healthcare Investors by 40.9% during the 2nd quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 268 shares during the last quarter. Ascentis Independent Advisors bought a new position in shares of Omega Healthcare Investors during the 1st quarter valued at about $35,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in shares of Omega Healthcare Investors during the 4th quarter valued at about $37,000. Finally, Rothschild Investment LLC boosted its holdings in shares of Omega Healthcare Investors by 283.7% during the 4th quarter. Rothschild Investment LLC now owns 944 shares of the real estate investment trust’s stock valued at $42,000 after purchasing an additional 698 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

About Omega Healthcare Investors

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Further Reading